UBS Assumes Twist Bioscience (TWST) at Neutral

UBS analyst Douglas Schenkel assumes coverage on Twist Bioscience (NASDAQ: TWST) with a Neutral rating and a price target of $144.00.

For an analyst ratings summary and ratings history on Twist Bioscience click here. For more ratings news on Twist Bioscience click here.

Shares of Twist Bioscience closed at $128.06 yesterday.

You May Also Be Interested In

• BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'
• JPMorgan Starts SK Hynix (SKHY) at Overweight
• Goldman Sachs Starts Abivax (ABVX) at Buy